Paper33780970
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.
Cele S and 22 others. Nature, 2021. Cited by 511 papers, by iCite.
Cite this record
ConductScience Library. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Papers, record 33780970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33780970
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neutralizing | Major topic |
| Antibodies, Viral | Major topic |
| COVID-19 | Major topic |
| Immune Evasion | Major topic |
| Mutation | Major topic |
| SARS-CoV-2 | Major topic |
| Animals | |
| Cell Line | |
| Chlorocebus aethiops | |
| Humans | |
| Immunization, Passive | |
| Neutralization Tests | |
| South Africa | |
| Time Factors | |
| Vero Cells | |
| COVID-19 Serotherapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DP2 DA040254 | NIDA NIH HHS | United States | DP2DA040254 | PubMed and NIH |
Source NIH RePORTER
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33112236 | Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. | Elife | 2020 | https://conductscience.org/library/papers/33112236 | PubMed |
| 2 | 33690265 | Detection of a SARS-CoV-2 variant of concern in South Africa. | Nature | 2021 | https://conductscience.org/library/papers/33690265 | PubMed |
| 3 | 33654292 | SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. | Nat Med | 2021 | https://conductscience.org/library/papers/33654292 | PubMed |
| 4 | 33592168 | Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. | Cell Host Microbe | 2021 | https://conductscience.org/library/papers/33592168 | PubMed |
| 5 | 34417349 | SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34417349 | PubMed |
| 6 | 33558724 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. | Nat Med | 2021 | https://conductscience.org/library/papers/33558724 | PubMed |
| 7 | 33853970 | Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. | Science | 2021 | https://conductscience.org/library/papers/33853970 | PubMed |
| 8 | 33567448 | mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. | Nature | 2021 | https://conductscience.org/library/papers/33567448 | PubMed |
| 9 | 33461210 | Evolution of antibody immunity to SARS-CoV-2. | Nature | 2021 | https://conductscience.org/library/papers/33461210 | PubMed |
| 10 | 33259788 | Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. | Cell Host Microbe | 2021 | https://conductscience.org/library/papers/33259788 | PubMed |
| 11 | 21849975 | Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. | Nature | 2011 | https://conductscience.org/library/papers/21849975 | PubMed |
| 12 | 33761326 | N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. | Cell | 2021 | https://conductscience.org/library/papers/33761326 | PubMed |
| 13 | 32540904 | Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. | Science | 2020 | https://conductscience.org/library/papers/32540904 | PubMed |
| 14 | 33684280 | Neutralizing Activity of BNT162b2-Elicited Serum. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33684280 | PubMed |
| 15 | 18552857 | Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. | Nat Med | 2008 | https://conductscience.org/library/papers/18552857 | PubMed |
| 16 | 33535027 | Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. | Cell Host Microbe | 2021 | https://conductscience.org/library/papers/33535027 | PubMed |
| 17 | 33772244 | Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. | Nat Med | 2021 | https://conductscience.org/library/papers/33772244 | PubMed |
| 18 | 32838945 | Growth, detection, quantification, and inactivation of SARS-CoV-2. | Virology | 2020 | https://conductscience.org/library/papers/32838945 | PubMed |
| 19 | 33930298 | Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. | Cell | 2021 | https://conductscience.org/library/papers/33930298 | PubMed |
| 20 | 33730471 | Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33730471 | PubMed |
Cited by413
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 511 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42643508 | Comparative systemic pathogenicity and host tropism of ancestral SARS-CoV-2, Delta, and Omicron EG.5 variants in K18-hACE2 mice. | Front Immunol | 2026 | https://conductscience.org/library/papers/42643508 | PubMed |
| 42385611 | Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates. | EBioMedicine | 2026 | https://conductscience.org/library/papers/42385611 | PubMed |
| 41979069 | Serology survey against multiple SARS-CoV-2 variants of residents in Tainan, Taiwan. | Virulence | 2026 | https://conductscience.org/library/papers/41979069 | PubMed |
| 41912532 | Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/41912532 | PubMed |
| 41884606 | Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant. | Virus Evol | 2026 | https://conductscience.org/library/papers/41884606 | PubMed |
| 41693861 | A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41693861 | PubMed |
| 41688712 | Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/41688712 | PubMed |
| 41685161 | A novel fusion protein of COVID-19 virus enhancing protection of Syrian hamsters infected with SARS-CoV-2. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41685161 | PubMed |
| 41301456 | Modeling the Mutational Effects on Biochemical Phenotypes of SARS-CoV-2 Using Molecular Fields. | Biomolecules | 2025 | https://conductscience.org/library/papers/41301456 | PubMed |
| 41258470 | A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/41258470 | PubMed |
| 40740485 | SARS-CoV-2 vaccines elicit differential Fc effector functions. | iScience | 2025 | https://conductscience.org/library/papers/40740485 | PubMed |
| 40434113 | The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells. | mSphere | 2025 | https://conductscience.org/library/papers/40434113 | PubMed |
| 40431733 | Evolution of Antiviral Drug Resistance in SARS-CoV-2. | Viruses | 2025 | https://conductscience.org/library/papers/40431733 | PubMed |
| 40205144 | Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus. | Infect Dis Ther | 2025 | https://conductscience.org/library/papers/40205144 | PubMed |
| 40133357 | Nightlife and low immunity drove transmission of SARS-CoV-2 gamma in Luxembourg, 2021. | Sci Rep | 2025 | https://conductscience.org/library/papers/40133357 | PubMed |
| 40040708 | Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19. | Front Immunol | 2025 | https://conductscience.org/library/papers/40040708 | PubMed |
| 40020259 | Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40020259 | PubMed |
| 39953108 | Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern. | Sci Rep | 2025 | https://conductscience.org/library/papers/39953108 | PubMed |
| 39936889 | Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale. | Biotechnol Bioeng | 2025 | https://conductscience.org/library/papers/39936889 | PubMed |
| 39873888 | Pharmacoinformatics-based screening and construction of a neutralizing anti-SARS-CoV-2 camelidae nanobody drug conjugate. | Mol Divers | 2025 | https://conductscience.org/library/papers/39873888 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| EEF1A2 | 1917 | PubTator's text mining | https://conductscience.org/library/genes/1917 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33780970
GET https://conductscience.org/api/papers/v1/33780970/authors?page=2